Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanling Li

Showing results (541-550 of 551) with videos related to

Pageof 56
Sort By:
Signal Transduction and Targeted Therapy|May 18, 2021
Rapid isolation and immune profiling of SARS-CoV-2 specific memory B cell in convalescent COVID-19 patients via LIBRA-seqBing He, Shuning Liu, Yuanyuan Wang, et al.
Schizophrenia Bulletin|May 16, 2024
Exploring Schizophrenia Classification Through Multimodal MRI and Deep Graph Neural Networks: Unveiling Brain Region-Specific Weight Discrepancies and Their Association With Cell-Type Specific Transcriptomic FeaturesJingjing Gao, Maomin Qian, Zhengning Wang, et al.
Nature Communications|September 30, 2025
Forward and reverse genomic screens enhance the understanding of phenotypic variation in a large Chinese rhesus macaque cohortBao-Lin Zhang, Yongxuan Chen, Yali Zhang, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 1, 2024
Efficacy and safety of topical minocycline foam (FMX101 4%) in treatment of Chinese subjects with moderate-to-severe facial acne vulgaris: A phase 3, multi-centre, randomized, double-blind, vehicle-controlled studyYan Le, Wenlin Yang, Jianyun Lu, et al.
Journal of the American Heart Association|March 4, 2026
ADJUVANT Randomized Controlled Trial: Rationale and DesignHongfei Sang, Zhilin Zheng, Heng Ni, et al.
Chinese Medical Journal|June 6, 2025
Equivalence of SYN008 versus omalizumab in patients with refractory chronic spontaneous urticaria: A multicenter, randomized, double-blind, parallel-group, active-controlled phase III studyJingyi Li, Yunsheng Liang, Wenli Feng, et al.
Journal of the American Academy of Dermatology|September 27, 2024
Efficacy and safety of vunakizumab in moderate-to-severe chronic plaque psoriasis: A randomized, double-blind, placebo-controlled phase 3 trialKexiang Yan, Fuqiu Li, Xiaodong Bi, et al.
Helicobacter|April 12, 2023
Characteristics of phenotypic antibiotic resistance of Helicobacter pylori and its correlation with genotypic antibiotic resistance: A retrospective study in NingxiaShengjuan Hu, Yan Zhou, Yanhong Deng, et al.
Research Square|September 15, 2025
Wearable-derived Sleep Measurements are Associated with Long-COVID in the RECOVER Adult CohortSairam Parthasarathy, Shari Brosnahan, Solveig Sieberts, et al.
Royal Society Open Science|June 26, 2025
Big team science reveals promises and limitations of machine learning efforts to model physiological markers of affective experienceNicholas A Coles, Bartosz Perz, Maciej Behnke, et al.
Pageof 56

Showing results (541-550 of 551) with videos related to

Sort By:
Pageof 56
Signal Transduction and Targeted Therapy|May 18, 2021
Rapid isolation and immune profiling of SARS-CoV-2 specific memory B cell in convalescent COVID-19 patients via LIBRA-seqBing He, Shuning Liu, Yuanyuan Wang, et al.
Schizophrenia Bulletin|May 16, 2024
Exploring Schizophrenia Classification Through Multimodal MRI and Deep Graph Neural Networks: Unveiling Brain Region-Specific Weight Discrepancies and Their Association With Cell-Type Specific Transcriptomic FeaturesJingjing Gao, Maomin Qian, Zhengning Wang, et al.
Nature Communications|September 30, 2025
Forward and reverse genomic screens enhance the understanding of phenotypic variation in a large Chinese rhesus macaque cohortBao-Lin Zhang, Yongxuan Chen, Yali Zhang, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 1, 2024
Efficacy and safety of topical minocycline foam (FMX101 4%) in treatment of Chinese subjects with moderate-to-severe facial acne vulgaris: A phase 3, multi-centre, randomized, double-blind, vehicle-controlled studyYan Le, Wenlin Yang, Jianyun Lu, et al.
Journal of the American Heart Association|March 4, 2026
ADJUVANT Randomized Controlled Trial: Rationale and DesignHongfei Sang, Zhilin Zheng, Heng Ni, et al.
Chinese Medical Journal|June 6, 2025
Equivalence of SYN008 versus omalizumab in patients with refractory chronic spontaneous urticaria: A multicenter, randomized, double-blind, parallel-group, active-controlled phase III studyJingyi Li, Yunsheng Liang, Wenli Feng, et al.
Journal of the American Academy of Dermatology|September 27, 2024
Efficacy and safety of vunakizumab in moderate-to-severe chronic plaque psoriasis: A randomized, double-blind, placebo-controlled phase 3 trialKexiang Yan, Fuqiu Li, Xiaodong Bi, et al.
Helicobacter|April 12, 2023
Characteristics of phenotypic antibiotic resistance of Helicobacter pylori and its correlation with genotypic antibiotic resistance: A retrospective study in NingxiaShengjuan Hu, Yan Zhou, Yanhong Deng, et al.
Research Square|September 15, 2025
Wearable-derived Sleep Measurements are Associated with Long-COVID in the RECOVER Adult CohortSairam Parthasarathy, Shari Brosnahan, Solveig Sieberts, et al.
Royal Society Open Science|June 26, 2025
Big team science reveals promises and limitations of machine learning efforts to model physiological markers of affective experienceNicholas A Coles, Bartosz Perz, Maciej Behnke, et al.
Pageof 56